Breaking News Instant updates and real-time market news.

MDT

Medtronic

$82.24

0.38 (0.46%)

11:24
02/15/18
02/15
11:24
02/15/18
11:24

Medtronic presents data showing 'positive' results from MiniMed system

Medtronic announced that new data from its at-home pediatric study of the MiniMed 670G system in patients 7-13 years of age were presented at the Advanced Technologies & Treatments for Diabetes 11th International Conference in Vienna, Austria. Study results mirror data from the pivotal trial of the system in adults and adolescents, showing patients spent more Time in Range, experienced less glycemic variability, less exposure to hypoglycemia and hyperglycemia, and reduced A1C compared to baseline data using sensor-augmented pumps. The MiniMed 670G system is currently FDA approved in the U.S. for people with type 1 diabetes 14 years of age and older. Data from this study was included in an FDA application in late January to seek future expansion of the current indication to include children 7-13 years of age. Medtronic is also evaluating the system in children 2-6 years of age and will present data from this trial at a future date. However, product labeling currently warns that the system may not be safe for children under age 7 or patients using less than 8 units of insulin per day.

  • 14

    Mar

  • 23

    Mar

MDT Medtronic
$82.24

0.38 (0.46%)

01/04/18
01/04/18
DOWNGRADE

Underperform
Dexcom to Underperform at Northland
As previously reported, Northland analyst Suraj Kalia downgraded Dexcom (DXCM) to Underperform from Market Perform after Abbott (ABT) announced Medicare coverage for its Libre FGM. The analyst believes it undercuts Dexcom's competitive advantages, and contends that there is additional headline risk vis-a-vis Medtronic' (MDT) Guardian Connect CGM approval in the pipeline. Further, Kalia believes Dexcom's stock is bound to be under pressure over the next 12-18 months.
01/18/18
PIPR
01/18/18
NO CHANGE
Target $82
PIPR
Overweight
Insulet is a favored diabetes play on business momentum, says Piper Jaffray
Piper Jaffray analyst JP McKim says he hosted calls yesterday with two Certified Diabetes Educators from a "high volume center" and learned that they expect Continuous Glucose Monitoring - CGM - to become a "standard of care" in the Type 1 market, which can reach penetration of 85% vs 40% today. The analyst says the findings support his view that CGM is set for accelerating growth. Kim also notes that the impact on Medtronic (MDT) is improving, while the business momentum at Insulet (PODD) continues. The analyst rates Insulet as his top choice, followed by Dexcom (DXCM) and Tandem Diabetes Care (TNDM) in the space, given the headline risk around Libre coverage and insufficient evidence of accelerating pump additions for the latter names respectively. Kim keeps his Overweight rating and $82 price target on Insulet.
02/12/18
OPCO
02/12/18
NO CHANGE
Target $67
OPCO
Outperform
Dexcom price target lowered to $67 from $72 at Oppenheimer
Oppenheimer analyst Steven Lichtman lowered his price target for Dexcom (DXCM) to $67 from $72 on lowered estimates, while reiterating an Outperform rating on the stock. The analyst recently surveyed high-volume U.S. endocrinologists on the latest in continuous glucose monitoring now with Abbott's (ABT) Libre Flash on the market. According to respondents, there is some impact on Dexcom new prescriptions since Libre launch and some current Dexcom patients are interested in switching, but the impact looks within expectations, he contends. Overall, Lichtman believes the rollouts of Libre and Medtronic's (MDT) 670G remain overhangs on Dexcom near-term, but his survey suggests an environment no worse than guidance and conditions on the ground should change again in 2H18 with approval of Dexcom's next-generation G6.
02/13/18
NEED
02/13/18
NO CHANGE
NEED
Needham a buyer of Medical Technologies product makers on Amazon headlines
After The Wall Street Journal report claiming that Amazon (AMZN) is attempting to become a major hospital supplier, Needham analyst Mike Matson said that he believes the e-commerce giant has typically disrupted middlemen much more than manufacturers. The analyst, who thinks Amazon's model may work for "lower tech" products but is unlikely to work with "higher tech" products, would be a buyer of Medical Technologies product maker stocks if they are down on weakness related to the headline risk represented by Amazon. However, Matson notes that he believe that Cantel Medical (CMD), CONMED (CNMD), Medtronic (MDT), Stryker (SYK) and Teleflex (TFX) generate a portion of their sales from "lower tech" products. Other stocks in MedTech manufacturing include AtriCure (ATRI), Cardiovascular Systems (CSII), Hill-Rom (HRC), K2M Group (KTWO), Mazor Robotics (MZOR), Zimmer Biomet (ZBH), Boston Scientific (BSX), Globus Medical (GMED), NuVasive (NUVA) and Wright Medical (WMGI).

TODAY'S FREE FLY STORIES

RMD

ResMed

$112.85

-2.54 (-2.20%)

09:13
12/17/18
12/17
09:13
12/17/18
09:13
Hot Stocks
ResMed subsidiary Brightree acquires Apacheta, terms not disclsoed »

Brightree announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WWE

WWE

$72.61

-1.06 (-1.44%)

, SKYAY

Sky

$0.00

(0.00%)

09:13
12/17/18
12/17
09:13
12/17/18
09:13
Hot Stocks
WWE, Sky extend partnership in New Zealand »

WWE (WWE) and SKY (SKYAY)…

WWE

WWE

$72.61

-1.06 (-1.44%)

SKYAY

Sky

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

OSTK

Overstock.com

$17.20

-0.77 (-4.28%)

09:11
12/17/18
12/17
09:11
12/17/18
09:11
Hot Stocks
Overstock.com, tZERO to develop commodity contract token for GSR Capital »

Overstock.com announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNC

Centene

$127.55

-5.3 (-3.99%)

09:10
12/17/18
12/17
09:10
12/17/18
09:10
Downgrade
Centene rating change  »

Centene downgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

CMTL

Comtech

$25.63

-0.38 (-1.46%)

09:10
12/17/18
12/17
09:10
12/17/18
09:10
Hot Stocks
Comtech receives $3.6M renewal agreement »

Comtech…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CONE

CyrusOne

$59.42

0.235 (0.40%)

, ESS

Essex Property Trust

$262.24

0.51 (0.19%)

09:09
12/17/18
12/17
09:09
12/17/18
09:09
Recommendations
CyrusOne, Essex Property Trust, Gaming and Leisure Properties, Hudson Pacific, Prologis, Regency Centers, SBA Communications, Store Capital analyst commentary  »

North American REIT…

CONE

CyrusOne

$59.42

0.235 (0.40%)

ESS

Essex Property Trust

$262.24

0.51 (0.19%)

GLPI

Gaming and Leisure Properties

$34.85

0.45 (1.31%)

HPP

Hudson Pacific

$30.08

-0.14 (-0.46%)

PLD

Prologis

$64.31

-0.35 (-0.54%)

REG

Regency Centers

$61.52

-0.74 (-1.19%)

SBAC

SBA Communications

$172.53

0.26 (0.15%)

STOR

Store Capital

$30.85

0.05 (0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

AGS

PlayAGS

$22.37

0.13 (0.58%)

09:09
12/17/18
12/17
09:09
12/17/18
09:09
Hot Stocks
PlayAGS to acquire Integrity Gaming for $49M in cash »

PlayAGS announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$61.75

-3.13 (-4.82%)

09:09
12/17/18
12/17
09:09
12/17/18
09:09
Hot Stocks
Icahn Automotive to acquire RPM Automotive, terms not disclosed »

Icahn Automotive Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FNJN

Finjan Holdings

$2.70

(0.00%)

, JNPR

Juniper

$27.77

-0.335 (-1.19%)

09:09
12/17/18
12/17
09:09
12/17/18
09:09
Hot Stocks
Jury finds non-infringement of Claim 10 of Finjan's '494 patent by Juniper »

Finjan Holdings (FNJN)…

FNJN

Finjan Holdings

$2.70

(0.00%)

JNPR

Juniper

$27.77

-0.335 (-1.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

AGS

PlayAGS

$22.37

0.13 (0.58%)

09:07
12/17/18
12/17
09:07
12/17/18
09:07
Hot Stocks
Breaking Hot Stocks news story on PlayAGS »

PlayAGS to acquire…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAESY

BAE Systems

$0.00

(0.00%)

09:06
12/17/18
12/17
09:06
12/17/18
09:06
Hot Stocks
BAE Systems receives $96.6M U.S. Army contract modification »

BAE Systems has received…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RPM

RPM

$60.45

0.2 (0.33%)

09:06
12/17/18
12/17
09:06
12/17/18
09:06
Hot Stocks
RPM acquires Siamons International, terms not disclosed »

RPM International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jan

NTRP

Neurotrope

$4.08

-0.18 (-4.23%)

09:05
12/17/18
12/17
09:05
12/17/18
09:05
Hot Stocks
Neurotrope announces publication of data from Phase 2 study of Bryostatin-1 »

Neurotrope announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDT

Medtronic

$93.78

-1.7 (-1.78%)

, SSNLF

Samsung

$0.00

(0.00%)

09:03
12/17/18
12/17
09:03
12/17/18
09:03
Hot Stocks
Medtronic announces FDA approval of InterStim smart programmer »

Medtronic (MDT) announced…

MDT

Medtronic

$93.78

-1.7 (-1.78%)

SSNLF

Samsung

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VOD

Vodafone

$20.12

0.035 (0.17%)

09:03
12/17/18
12/17
09:03
12/17/18
09:03
Upgrade
Vodafone rating change  »

Vodafone upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BT

BT Group

$15.93

-0.095 (-0.59%)

09:03
12/17/18
12/17
09:03
12/17/18
09:03
Upgrade
BT Group rating change  »

BT Group upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GG

Goldcorp

$9.14

-0.315 (-3.33%)

09:03
12/17/18
12/17
09:03
12/17/18
09:03
Upgrade
Goldcorp rating change  »

Goldcorp upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$192.06

-5.41 (-2.74%)

09:02
12/17/18
12/17
09:02
12/17/18
09:02
Hot Stocks
Amgen submits BLA for ABP 710 to FDA »

Amgen announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

MET

MetLife

$38.90

-0.62 (-1.57%)

09:01
12/17/18
12/17
09:01
12/17/18
09:01
Recommendations
MetLife analyst commentary  »

MetLife price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

IONS

Ionis Pharmaceuticals

$52.97

-0.52 (-0.97%)

09:00
12/17/18
12/17
09:00
12/17/18
09:00
Recommendations
Ionis Pharmaceuticals analyst commentary  »

Needham names Ionis a top…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLF

Financial Select Sector

$24.25

-0.24 (-0.98%)

09:00
12/17/18
12/17
09:00
12/17/18
09:00
Technical Analysis
Technical Take: Financial Select Sector at new 52-week low »

The Financial Select…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:00
12/17/18
12/17
09:00
12/17/18
09:00
General news
Treasury Action: yields stabilized above lows »

Treasury Action: yields…

08:58
12/17/18
12/17
08:58
12/17/18
08:58
General news
Futures pointing to extension of Friday selloff »

Stock futures are trading…

ADBE

Adobe

$230.00

-17.71 (-7.15%)

08:57
12/17/18
12/17
08:57
12/17/18
08:57
Conference/Events
RBC Capital Internet analysts to hold an analyst/industry conference call »

Internet Analysts discuss…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 07

    Jan

LITE

Lumentum

$43.46

-0.4 (-0.91%)

, OCLR

Bought by LITE

$0.00

(0.00%)

08:56
12/17/18
12/17
08:56
12/17/18
08:56
Recommendations
Lumentum, Bought by LITE analyst commentary  »

Lumentum can continue…

LITE

Lumentum

$43.46

-0.4 (-0.91%)

OCLR

Bought by LITE

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.